SS

Surinder Singh

Active Director Director DIN 01148229
DIN 01148229 First appointment Jan 2001 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2001
Shareholding value •••• Premium profile

About Surinder Singh

Data last updated:

Surinder Singh is a Director at Synorga Pharmaceuticals Ltd (since 2001). The company operates in Trading. Synorga Pharmaceuticals Ltd reported revenue of ₹18.90 Cr (FY 2017).

DIN 01148229
Primary Designation Director
Industry Trading
First Appointment 30 Jan 2001
Oldest Company Age 45 yrs
Largest company Synorga Pharmaceuticals Ltd · ₹18.90 Cr (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synorga Pharmaceuticals Ltd U24230DL1981PLC011952
Director30 Jan 20011981₹18.90 Cr (FY 2017)Active

Board colleagues of Surinder Singh

Directorship timeline

Open interactive timeline →
Synorga Pharmaceuticals Ltd
Premium access

Shareholding and investment profile for Surinder Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surinder Singh

Surinder Singh currently holds 1 directorship: Synorga Pharmaceuticals Ltd (Director, since 30 Jan 2001, revenue ₹18.90 Cr (FY 2017)).

Surinder Singh was first appointed on 30 Jan 2001 as Director at Synorga Pharmaceuticals Ltd.

The current boards of Surinder Singh's companies include Kultaran Singh Kochhar (Synorga Pharmaceuticals Ltd), Manmohan Singh Phull (Synorga Pharmaceuticals Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available